In-House Counsel | Kisaco Research

In-House Counsel

As an in-house counsel in the pharmaceutical and biotech industries, staying ahead of evolving patent litigation trends, regulatory updates, and strategic enforcement approaches is essential. The 5th Anniversary of The Pharma & Biotech Patent Litigation Europe event provides a unique platform to gain exclusive insights from industry-leading experts, connect with fellow in-house professionals, and navigate the latest UPC rulings, cross-border disputes, and competition law developments. With a 50% in-house counsel audience and tailored sessions covering regulatory changes, licensing strategies, and patent litigation best practices, this conference is designed to equip you with the knowledge and connections necessary to protect and maximize your company’s IP assets.

OUR IN-HOUSE AUDIENCE

35+
Different Countries
50%
Of All Attendees Are In-House Counsels
15+
Dedicated Net-Working Hours
50%
Representation of Generics & Innovators

The Generic & Innovator Experience

Your Benefits

  1. Industry-Specific Litigation Insights: Gain invaluable expertise on cross-border patent litigation, preliminary injunctions, SPCs, and second medical use claims, helping refine legal strategies for pharma and biotech companies.
  2. Networking with Peers & Experts: Engage with a 50% in-house counsel audience and 550+ attendees from 35+ countries, fostering long-term connections with key decision-makers in the industry.
  3. Regulatory & UPC Updates: Stay ahead of critical European Commission reforms, Bolar Exemption case law, and Unitary SPC developments, ensuring compliance and strategic adaptation to evolving legal frameworks.
  4. Benchmarking & Best Practices: Learn from 55+ expert in-house speakers and industry-leading professionals, comparing approaches to patent enforcement, licensing, settlements, and regulatory strategies.
  5. Exclusive Pre-Event UPC Litigation Forum: Get a deep dive into the latest UPC rulings, injunction strategies, and competition law impacts, equipping in-house teams with knowledge crucial for strategic decision-making.

OUR INHOUSE ATTENDEES INCLUDE